V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002487 | 240010817 | 1.63 | 67.7 | Palliative (P) | 2018-08-16 | 2018-08-30 | AZACITIDINE + VENETOCLAX | 02 | N | DABRAFENIB | 100475949 |
| 240002489 | 240010818 | 1.75 | 13.6 | null | 2021-03-29 | 2021-04-01 | BUSULFAN + CYCLO | N | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101869442 |
| 240002494 | 240010819 | 1.82 | null | Curative (C) | null | 2020-04-16 | TRANSPLANT BEAM | null | null | VENETOCLAX | 101692205 |
| 240002529 | 240010820 | 1.52 | 29.8 | null | 2020-02-29 | 2020-12-08 | RUXOLITINIB | 02 | null | AML DOWNS AIE | 101794967 |
| 240002542 | 240010825 | 1.74 | 82.7 | Curative (C) | 2022-01-10 | 2022-01-10 | Venetoclax | null | N | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 101652203 |
| 240002544 | 240010826 | 1.51 | 112.5 | null | 2020-12-11 | 2020-12-12 | Alemtuzumab | 02 | null | CISPLATIN + GEMCITABINE + RITUXIMAB | 100336254 |
| 240002573 | 240010829 | 0 | 56.8 | Curative (C) | null | 2020-12-28 | FLAG + Idarubicin | N | N | FLAIR TRIAL | 100651140 |
| 240002577 | 240010830 | 1.85 | 66.2 | null | null | 2021-06-23 | NHL IntB NHL ritux2010 GpB COPADM | Y | null | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 101309020 |
| 240002583 | 240010831 | 1.72 | 66.6 | Curative (C) | 2021-08-25 | 2021-08-26 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | ALEMTUZUMAB + CYTARABINE + ETOPOSIDE + FLUDARABINE + LOMUSTINE + MELPHALAN | 100560456 |
| 240002597 | 240010832 | 1.56 | 101.2 | Palliative (P) | 2018-10-21 | 2018-10-21 | CYCLOPHOSPHAMIDE + FLUDARABINE | 02 | null | IMATINIB | 101029319 |
| 240002610 | 240010833 | 1.54 | 116 | Curative (C) | 2019-12-30 | 2019-12-31 | Clofarabine + Cytarabine | null | N | ANAGRELIDE | 100238819 |
| 240002616 | 240010834 | 1.74 | 73.2 | null | null | 2019-01-15 | Ixazomib + Lenalidomide | 02 | null | CYTARABINE HIGH DOSE | 100620403 |
| 240002619 | 240010835 | 1.73 | 94 | null | null | 2019-08-28 | Cladribine (subcut) 5 days | null | null | NHL 2003 | 101456528 |
| 240002620 | 240010836 | 1.63 | 85 | Palliative (P) | 2020-04-26 | 2020-05-15 | IMATINIB | 02 | null | CLADRIBINE | 100852396 |
| 240002621 | 240010837 | 1.67 | 16.8 | null | 2020-01-29 | 2021-03-07 | null | N | null | NIVOLUMAB | 101627133 |
| 240002631 | 240010838 | null | 71.6 | null | 2019-06-14 | 2019-06-23 | Bortezomib + Thalidomide +/- Dex | 02 | null | ALL UKALL2011 MAINTENANCE | 100610839 |
| 240002637 | 240010839 | 1.75 | 59.2 | Disease modification (D) | 2018-03-10 | 2018-03-31 | Trial Unspecified | 02 | N | RUXOLITINIB | 100056675 |
| 240002657 | 240010841 | 1.69 | 75.9 | Curative (C) | 2020-12-18 | 2020-12-23 | null | 02 | null | THALIDOMIDE | 100373006 |
| 240002659 | 240010842 | 1 | 116.7 | Curative (C) | 2018-10-11 | 2018-10-15 | Cyclophosphamide + Dex + Rituximab | 02 | null | AML MYECHILD 01 HD ARAC | 101341389 |
| 240002661 | 240010843 | 1.85 | 82.3 | Curative (C) | 2020-02-04 | 2020-02-06 | ALL UKALL2011 Std BFM Cons B | 02 | N | CYTARABINE HIGH DOSE | 100392129 |
| 240002676 | 240010844 | 1.57 | 51.3 | null | null | 2019-10-31 | Venetoclax | null | N | CYTARABINE + FLUDARABINE + IDARUBICIN | 101764303 |
| 240002681 | 240010845 | 1.56 | 57.4 | Adjuvant (A) | 2017-03-09 | 2017-04-19 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | FLAIR TRIAL | 101392613 |
| 240002704 | 240010848 | 1.77 | 85 | Curative (C) | 2021-04-04 | 2021-04-04 | Methotrexate intrathecal | 02 | null | BUSULFAN | 101247286 |
| 240002722 | 240010852 | 1.79 | 73.7 | null | 2018-02-19 | 2018-02-21 | null | 02 | null | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100415407 |
| 240002723 | 240010853 | 1.62 | 61.5 | Palliative (P) | 2019-09-27 | 2019-10-01 | RUXOLITINIB | 02 | N | STS NON-RHABDO EPSSG 2005 VBL/MTX | 100079064 |
| 240002730 | 240010854 | 1.63 | 76.5 | null | 2020-10-12 | 2020-10-26 | BEAM | 02 | N | FCR | 100332081 |
| 240002754 | 240010855 | 1.69 | 91.6 | Curative (C) | 2021-04-14 | 2021-08-08 | CISPLATIN + GEMCITABINE + RITUXIMAB | 02 | N | BUSULFAN | 100630392 |
| 240002757 | 240010856 | 1.7 | 51 | 03 | 2021-07-01 | 2021-07-28 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 101368299 |
| 240002760 | 240010857 | 1.77 | 50.7 | null | 2021-03-24 | 2021-03-26 | null | 02 | null | INTERFERON ALFA | 101835631 |
| 240002786 | 240010861 | 1.54 | 13.4 | 03 | 2017-10-13 | 2018-03-07 | null | 02 | null | ANAGRELIDE | 100601343 |
| 240002787 | 240010862 | 1.57 | 66 | Curative (C) | null | 2022-02-02 | null | 2 | null | VENETOCLAX | 100469034 |
| 240002805 | 240010864 | 1.6 | 80.8 | Curative (C) | 2020-11-24 | 2020-11-24 | IMATINIB | 02 | null | AML MYECHILD 01 TRIPLE IT | 100141254 |
| 240002815 | 240010865 | 1.65 | 131 | null | null | 2020-03-06 | AML Interim Guidelines FLAG-Ida | null | null | NOT MATCHED | 100137843 |
| 240002817 | 240010866 | 1.71 | 52.2 | Curative (C) | 2020-01-28 | 2020-01-29 | IVOSIDENIB | N | null | RUXOLITINIB | 100255854 |
| 240002829 | 240010868 | 1.5 | 85 | Disease modification (D) | 2019-08-28 | 2019-08-31 | ALL UKALL2011 Maintenance B4 | 02 | null | RUXOLITINIB | 101182933 |
| 240002831 | 240010869 | null | 79.5 | 03 | 2020-12-10 | 2020-12-10 | R CODOX M | N | N | CYTARABINE HIGH DOSE | 100005624 |
| 240002839 | 240010871 | 1.6 | 116.7 | Curative (C) | 2019-01-17 | 2019-01-20 | null | 02 | N | CYTARABINE HIGH DOSE | 100264509 |
| 240002844 | 240010873 | null | null | Curative (C) | null | 2022-05-06 | GEM-P | N | null | PEG INTERFERON | 100157504 |
| 240002845 | 240010874 | 1.43 | 112.5 | 03 | 2020-02-20 | 2020-02-21 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | N | PEG INTERFERON | 101713235 |
| 240000506 | 240010878 | 1.7 | 54.6 | Curative (C) | 2021-12-19 | 2022-01-13 | Cytarabine High Dose | 02 | N | CYCLOPHOSPHAMIDE | 100084458 |
| 240000626 | 240010880 | 1.77 | 66.9 | Curative (C) | 2017-11-15 | 2017-11-18 | AML Interim Guidelines FLAG-Ida | 01 | N | GEMCITABINE | 101019381 |
| 240000738 | 240010881 | 1.68 | 58.2 | null | null | 2019-01-02 | Midostaurin | N | null | TRANSPLANT ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100312022 |
| 240001189 | 240010884 | 1.79 | 131.8 | null | null | 2022-05-11 | null | null | null | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 101530642 |
| 240001659 | 240010885 | 0 | 34.9 | null | 2019-04-29 | 2019-04-29 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | AML RELAPSED FLA | 100079215 |
| 240002338 | 240010887 | 1.66 | 106 | null | 2018-05-05 | 2018-05-09 | BEAM | 02 | null | ANAGRELIDE | 101804494 |
| 240002801 | 240010888 | 1.51 | 62 | null | null | 2021-03-25 | ALL UKALL2011 IndB Std Dex (PegAsp) | N | null | CHLORAMBUCIL + OBINUTUZUMAB | 100815906 |
| 240000724 | 240010938 | null | null | null | null | 2019-12-10 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100833427 |
| 240000787 | 240010948 | null | null | null | null | 2018-09-29 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100335001 |
| 240000812 | 240010955 | null | null | Curative (C) | null | 2016-03-23 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101159605 |
| 240000853 | 240010963 | null | null | null | null | 2019-10-27 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101526786 |